ChenGuang Biotech Group Statistics
Total Valuation
SHE:300138 has a market cap or net worth of CNY 6.03 billion. The enterprise value is 7.25 billion.
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | May 21, 2026 |
Share Statistics
SHE:300138 has 483.10 million shares outstanding. The number of shares has decreased by -0.88% in one year.
| Current Share Class | 483.10M |
| Shares Outstanding | 483.10M |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 27.54% |
| Owned by Institutions (%) | 14.70% |
| Float | 350.07M |
Valuation Ratios
The trailing PE ratio is 18.00 and the forward PE ratio is 13.23.
| PE Ratio | 18.00 |
| Forward PE | 13.23 |
| PS Ratio | 0.92 |
| PB Ratio | 1.76 |
| P/TBV Ratio | 1.95 |
| P/FCF Ratio | 78.57 |
| P/OCF Ratio | 26.14 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 12.42, with an EV/FCF ratio of 94.38.
| EV / Earnings | 21.61 |
| EV / Sales | 1.11 |
| EV / EBITDA | 12.42 |
| EV / EBIT | 18.68 |
| EV / FCF | 94.38 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.27.
| Current Ratio | 1.32 |
| Quick Ratio | 0.76 |
| Debt / Equity | 1.27 |
| Debt / EBITDA | 7.60 |
| Debt / FCF | 57.70 |
| Interest Coverage | 3.73 |
Financial Efficiency
Return on equity (ROE) is 9.95% and return on invested capital (ROIC) is 6.78%.
| Return on Equity (ROE) | 9.95% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 6.78% |
| Return on Capital Employed (ROCE) | 10.29% |
| Weighted Average Cost of Capital (WACC) | 4.38% |
| Revenue Per Employee | 3.15M |
| Profits Per Employee | 161,328 |
| Employee Count | 2,079 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, SHE:300138 has paid 50.67 million in taxes.
| Income Tax | 50.67M |
| Effective Tax Rate | 12.91% |
Stock Price Statistics
The stock price has decreased by -6.56% in the last 52 weeks. The beta is 0.34, so SHE:300138's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -6.56% |
| 50-Day Moving Average | 11.95 |
| 200-Day Moving Average | 11.79 |
| Relative Strength Index (RSI) | 50.66 |
| Average Volume (20 Days) | 8,024,138 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300138 had revenue of CNY 6.54 billion and earned 335.40 million in profits. Earnings per share was 0.69.
| Revenue | 6.54B |
| Gross Profit | 758.21M |
| Operating Income | 388.10M |
| Pretax Income | 392.41M |
| Net Income | 335.40M |
| EBITDA | 582.54M |
| EBIT | 388.10M |
| Earnings Per Share (EPS) | 0.69 |
Full Income Statement Balance Sheet
The company has 3.27 billion in cash and 4.43 billion in debt, with a net cash position of -1.16 billion or -2.39 per share.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 4.43B |
| Net Cash | -1.16B |
| Net Cash Per Share | -2.39 |
| Equity (Book Value) | 3.48B |
| Book Value Per Share | 7.08 |
| Working Capital | 1.64B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 230.83 million and capital expenditures -154.03 million, giving a free cash flow of 76.80 million.
| Operating Cash Flow | 230.83M |
| Capital Expenditures | -154.03M |
| Depreciation & Amortization | 194.43M |
| Net Borrowing | 603.86M |
| Free Cash Flow | 76.80M |
| FCF Per Share | 0.16 |
Full Cash Flow Statement Margins
Gross margin is 11.59%, with operating and profit margins of 5.93% and 5.13%.
| Gross Margin | 11.59% |
| Operating Margin | 5.93% |
| Pretax Margin | 6.00% |
| Profit Margin | 5.13% |
| EBITDA Margin | 8.90% |
| EBIT Margin | 5.93% |
| FCF Margin | 1.17% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 2.40%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 2.40% |
| Dividend Growth (YoY) | 130.77% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 74.37% |
| FCF Payout Ratio | 188.71% |
| Buyback Yield | 0.88% |
| Shareholder Yield | 3.28% |
| Earnings Yield | 5.55% |
| FCF Yield | 1.27% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for SHE:300138 is 15.21, which is 21.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 15.21 |
| Price Target Difference | 21.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.45% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 27, 2018. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 27, 2018 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:300138 has an Altman Z-Score of 2.15 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.15 |
| Piotroski F-Score | 4 |